Trimodality Therapy in the Treatment of Stage III N2‐Positive Non‐Small Cell Lung Cancer: A National Cancer Database Analysis

BACKGROUND: Significant controversy remains regarding the care of patients with clinical stage III (N2‐positive) NSCLC. Although multimodality therapy is effective, the roles of surgery, chemotherapy, and radiotherapy are not fully defined and the optimal treatment approach is not firmly established...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncologist
Hlavní autoři: Behera, Madhusmita, Steuer, Conor E., Liu, Yuan, Fernandez, Felix, Fu, Chao, Higgins, Kristin A., Gillespie, Theresa W., Pakkala, Suchita, Pillai, Rathi N., Force, Seth, Belani, Chandra P., Khuri, Fadlo R., Curran, Walter J., Ramalingam, Suresh S.
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley & Sons, Inc. 2020
Témata:
Lung Cancer
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7288644/
https://ncbi.nlm.nih.gov/pubmed/31943520
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0661
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky